Martin Austermann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Martin Austermann has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Giovanni Torsello
Department of Vascular Surgery, St. Franziskus Hospital Münster, Münster, Germany
2 shared publications- Konstantinos P. Donas
Rhein Main Vascular Center, Department of Vascular and Endovascular Surgery, Asklepios Clinics Langen, Paulinen Wiesbaden, 63225 Langen, Germany
2 shared publications Marco Virgilio Usai
2 shared publications- Theodosios Bisdas
Department of Vascular Surgery, Athens Medical Center, Athens, Greece
2 shared publications Yousef Shehada
2 shared publicationsAlexander Gombert
Department of Vascular Surgery, University Hospital RWTH Aachen, Aachen, Germany
1 shared publication
Latest Publications
- 25 February 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (3) , 318-325
Three Year Data on the Performance of Three Renal Artery Bridging Stent Grafts in Branched Endovascular Repair of Thoraco-Abdominal Pathologies
- 25 February 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (3) , 318-325
Three Year Data on the Performance of Three Renal Artery Bridging Stent Grafts in Branched Endovascular Repair of Thoraco-Abdominal Pathologies
- 1 February 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 73 (2) , 433-442
Outcomes of elective use of the chimney endovascular technique in pararenal aortic pathologic processes
- 1 February 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 73 (2) , 433-442
Outcomes of elective use of the chimney endovascular technique in pararenal aortic pathologic processes
- 1 November 2019
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 70 (5) , e133-e134
AAA 5. Bridging Stent Grafts in Fenestrated Aortic Repair: Performance of Different Covered Stents for This Indication in an In Vitro Model
- 1 November 2019
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 70 (5) , e133-e134
AAA 5. Bridging Stent Grafts in Fenestrated Aortic Repair: Performance of Different Covered Stents for This Indication in an In Vitro Model
- 26 May 2017
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 24 (4) , 604-610
Initial Experience With the 6-F and 8-F Indigo Thrombectomy System for Acute Renovisceral Occlusive Events
Purpose: To examine the safety and effectiveness of the new large-bore Indigo thrombectomy catheters to treat patients with acute renovisceral occlusion without the need of thrombolytic agents. Methods: Between November 2015 and 2016, 7 consecutive patients (mean age 65±5 years; 5 men) with acute renovisceral artery occlusion were treated with the new large-bore (6-F and 8-F) vacuum-assisted thrombectomy catheters. The occluded vessels were 6 renal arteries and 3 superior mesenteric arteries (SMAs); 5 of the 9 thromboses were in bridging stent-grafts associated with branched endografts. Mean lesion length was 63±36 mm. For the SMA and all bridging stent-grafts, 8-F catheters are routinely used through a brachial access, whereas 6-F aspiration catheters were used in native renal arteries. Technical success was defined as restoration of antegrade blood flow without the need of lysis or alternative thrombectomy/revascularization strategies. Safety endpoints were any in-hospital major adverse events. Pre- and postoperative hemoglobin and hematocrit levels were compared. Results: Technical success was 100% with no major adverse events or fatal bleeding. The mean amount of aspirated blood was 219±97 mL. The mean hemoglobin and hematocrit values were 13.1±2.1 g/dL and 39%±6% prior to and 11.6±2.2 g/dL (p=0.001) and 34%±6% (p<0.0001) directly after the intervention, respectively. Conclusion: The first assessment of the new large-bore Indigo thrombectomy catheters showed them to be an effective and safe lysis-free frontline therapy for acute renovisceral artery occlusion in a small cohort of patients. New users should be fully aware of the potential blood loss during aspiration.
- 26 May 2017
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 24 (4) , 604-610
Initial Experience With the 6-F and 8-F Indigo Thrombectomy System for Acute Renovisceral Occlusive Events
Purpose: To examine the safety and effectiveness of the new large-bore Indigo thrombectomy catheters to treat patients with acute renovisceral occlusion without the need of thrombolytic agents. Methods: Between November 2015 and 2016, 7 consecutive patients (mean age 65±5 years; 5 men) with acute renovisceral artery occlusion were treated with the new large-bore (6-F and 8-F) vacuum-assisted thrombectomy catheters. The occluded vessels were 6 renal arteries and 3 superior mesenteric arteries (SMAs); 5 of the 9 thromboses were in bridging stent-grafts associated with branched endografts. Mean lesion length was 63±36 mm. For the SMA and all bridging stent-grafts, 8-F catheters are routinely used through a brachial access, whereas 6-F aspiration catheters were used in native renal arteries. Technical success was defined as restoration of antegrade blood flow without the need of lysis or alternative thrombectomy/revascularization strategies. Safety endpoints were any in-hospital major adverse events. Pre- and postoperative hemoglobin and hematocrit levels were compared. Results: Technical success was 100% with no major adverse events or fatal bleeding. The mean amount of aspirated blood was 219±97 mL. The mean hemoglobin and hematocrit values were 13.1±2.1 g/dL and 39%±6% prior to and 11.6±2.2 g/dL (p=0.001) and 34%±6% (p<0.0001) directly after the intervention, respectively. Conclusion: The first assessment of the new large-bore Indigo thrombectomy catheters showed them to be an effective and safe lysis-free frontline therapy for acute renovisceral artery occlusion in a small cohort of patients. New users should be fully aware of the potential blood loss during aspiration.
- 1 July 2015
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 50 (1) , 60-70
Performance of Bridging Stent Grafts in Fenestrated and Branched Aortic Endografting
- 1 July 2015
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 50 (1) , 60-70
Performance of Bridging Stent Grafts in Fenestrated and Branched Aortic Endografting
- 1 August 2013
- Published by International Society of Endovascular Specialists in Journal of Endovascular Therapy
- Vol. 20 (4) , 461-468
Technical Assessment of the Preloaded Fenestrated Stent-Graft in the Management of Pararenal Aortic Aneurysms
Purpose To assess the effectiveness of the 20-F preloaded fenestrated stent-graft (FSG) to facilitate safe and quick catheterization of both renal arteries and its impact on relevant procedure variables in the management of pararenal aortic aneurysms (PAAs). Methods Between June 2012 when preloaded FSG became available in our institution and February 2013, 10 patients (9 men; mean age 70±10 years) with PAAs were treated by the same surgeon with preloaded FSGs consisting of 3 fenestrations with/without a scallop for the celiac trunk. In the same time frame, 12 patients (11 men; mean age 72±8 years) received standard FSGs with the same fenestration configuration by the same surgeon and were considered as controls. The decision to use the standard vs. preloaded FSG was random; no selection criteria were applied. Main outcome measures were the time interval between insertion of the main graft and advancement of sheaths in all target vessels, total operating time, the amount of iodine, the radiation dose area product, and the fluoroscopy time. Results The median time to sheath introduction into the fenestrations in the preloaded FSG group was significantly shorter (19 minutes, range 15–36) vs. the 48 minutes (range 30–65) of the control group (p=0.001). The mean operating time was 178±28 minutes in test group and 251±50 minutes in the controls (p=0.006). The median fluoroscopy time was shorter in the preloaded FSG group (61 minutes, range 41–73) vs. 83 minutes (range 51–290) in the controls (p=0.002). The radiation dose was significantly lower [3 mGym2 (range 1.4–6.1) vs. 4.9 mGym2 (range 3.6–12.7), p=0.004], as was the amount of iodine (37.4±9.5 g vs. 50±11.7 g, p=0.01). Conclusion The technique of fenestrated stent-grafting for PAAs using a preloaded device is feasible. Compared to standard FSGs, the preloaded design seems to be beneficial in terms of reducing the times for catheterization of all target vessels (60% shorter), fluoroscopy (27% shorter), and the procedure (29% shorter). The radiation dose and the amount of iodine used were less as well (39% and 25%, respectively).
- 1 August 2013
- Published by International Society of Endovascular Specialists in Journal of Endovascular Therapy
- Vol. 20 (4) , 461-468
Technical Assessment of the Preloaded Fenestrated Stent-Graft in the Management of Pararenal Aortic Aneurysms
Purpose To assess the effectiveness of the 20-F preloaded fenestrated stent-graft (FSG) to facilitate safe and quick catheterization of both renal arteries and its impact on relevant procedure variables in the management of pararenal aortic aneurysms (PAAs). Methods Between June 2012 when preloaded FSG became available in our institution and February 2013, 10 patients (9 men; mean age 70±10 years) with PAAs were treated by the same surgeon with preloaded FSGs consisting of 3 fenestrations with/without a scallop for the celiac trunk. In the same time frame, 12 patients (11 men; mean age 72±8 years) received standard FSGs with the same fenestration configuration by the same surgeon and were considered as controls. The decision to use the standard vs. preloaded FSG was random; no selection criteria were applied. Main outcome measures were the time interval between insertion of the main graft and advancement of sheaths in all target vessels, total operating time, the amount of iodine, the radiation dose area product, and the fluoroscopy time. Results The median time to sheath introduction into the fenestrations in the preloaded FSG group was significantly shorter (19 minutes, range 15–36) vs. the 48 minutes (range 30–65) of the control group (p=0.001). The mean operating time was 178±28 minutes in test group and 251±50 minutes in the controls (p=0.006). The median fluoroscopy time was shorter in the preloaded FSG group (61 minutes, range 41–73) vs. 83 minutes (range 51–290) in the controls (p=0.002). The radiation dose was significantly lower [3 mGym2 (range 1.4–6.1) vs. 4.9 mGym2 (range 3.6–12.7), p=0.004], as was the amount of iodine (37.4±9.5 g vs. 50±11.7 g, p=0.01). Conclusion The technique of fenestrated stent-grafting for PAAs using a preloaded device is feasible. Compared to standard FSGs, the preloaded design seems to be beneficial in terms of reducing the times for catheterization of all target vessels (60% shorter), fluoroscopy (27% shorter), and the procedure (29% shorter). The radiation dose and the amount of iodine used were less as well (39% and 25%, respectively).